Nomura Holdings’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-32,400
Closed -$328K 2535
2021
Q3
$328K Sell
32,400
-17,600
-35% -$177K ﹤0.01% 1554
2021
Q2
$502K Sell
50,000
-143
-0.3% -$1.45K ﹤0.01% 1330
2021
Q1
$509K Buy
+50,143
New +$533K ﹤0.01% 1342

Other funds holding MTACU

Nomura Holdings's MTACU Position: Q4 2021 in Review

Nomura Holdings sold out of MedTech Acquisition Corporation Unit (MTACU) in Q4 2021, closing a stake of 32,400 shares — an estimated $328K sold.

Nomura Holdings first reported a position in MTACU in Q1 2021 and held it in 3 quarters. The position peaked at $509K in Q1 2021. 11 funds tracked by Wall St. Rank hold MTACU as of Q4 2021.

  • Nomura Holdings reported no remaining MedTech Acquisition Corporation Unit position as of Q4 2021 after selling out during the quarter.
  • Nomura Holdings sold 32,400 MedTech Acquisition Corporation Unit shares in Q4 2021, an estimated $328K.
  • Nomura Holdings first reported a position in MedTech Acquisition Corporation Unit in Q1 2021 and held it in 3 quarters.
  • Nomura Holdings's MedTech Acquisition Corporation Unit position peaked at $509K in Q1 2021.
  • 11 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q4 2021.

Based on Nomura Holdings's 13F filing for Q4 2021, filed 14 Feb 2022.